US gives initial approval to pig virus vaccine

The U.S. government has given conditional approval to the first vaccine licensed to fight a deadly pig virus.

Porcine epidemic diarrhea has killed millions of baby pigs since it showed up in the United States last year and is partly responsible for recent increases in pork prices.

The U.S. Department of Agriculture gave conditional approval last week to a vaccine produced by Iowa-based Harrisvaccines. The is being used mostly to boost immunity in sows that have had the disease so they can better pass on antibodies to their young.

Company spokesman Joel Harris said Wednesday that one challenge is immunity to PED doesn't seem to last like it does with many viruses. He says it might last only a few months.

Other companies also have been working on vaccines.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

US orders farms to report pig virus infections

Apr 18, 2014

The U.S. government is starting a new program to help monitor and possibly control the spread of a virus that has killed millions of pigs since showing up in the country last year.

Recommended for you

Xtoro approved for swimmer's ear

12 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

13 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.